# What This Bill Does

This bill creates a new Department of Defense program that gives money to private companies to build, expand, or upgrade factories that make biological products the military needs. Think of it as the government investing in domestic manufacturing to reduce dependence on foreign suppliers for critical materials and chemicals that the military relies on.

The program works by offering competitive grants to eligible private companies. If a company wants to build or upgrade a biomanufacturing facility—a factory that uses biological systems like bacteria or enzymes to produce chemicals and materials—they can apply for federal funding. The Defense Department will evaluate applications based on several factors: whether the technology strengthens America's supply chains, whether it could help the military, how flexible the facility is to produce different products, and whether spreading these factories across different parts of the country makes sense geographically.

Companies that receive funding can use it to build new facilities, upgrade existing ones, or develop the business plans needed to get started. The goal is to ensure the military has reliable domestic sources for critical biological products rather than depending on other countries. The program lasts for ten years, though the President can extend it if national security needs require it. Throughout the program, the Defense Department must report to Congress about which companies received money, where their facilities are located, what products they'll make, and whether the program is actually meeting military and national security goals.

For everyday Americans, this could mean new manufacturing jobs in communities that get these facilities, though the bill doesn't guarantee local hiring. It also represents a government investment in domestic production capacity, which supporters argue strengthens national security and reduces supply chain vulnerabilities, particularly for materials the military depends on.